Currently, an ongoing phase III, multicenter, randomized, sham-controlled, double-blind trial is evaluating AT-04s efficacy and safety for endometriosis-related pain (dysmenorrhea, dyspareunia, chronic pelvic pain), with the primary outcome being the change in Numeric Rating Scale score at 16 weeks (36)
Cng tm hiu nhng cng dng ca glutathione i vi c sc khe v ln da thi no
Overexpression of G6PD is associated with high risks of recurrent metastasis and poor progression-free survival in primary breast carcinoma
HOW OFTEN ARE INJECTIONS ADMINISTERED
Monitoring Requirements: Regular check-ins with your Healthcare Provider may be required to evaluate treatment progress and adjust dosage or frequency as needed
Eating small, frequent meals can also prevent blood pressure drops that occur after large meals